Obsidian Therapeutics, Inc. cash flow statement OBX

No matching figures were found for this statement.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
OBX (Nasdaq)
Fiscal year ends
December 31
Headquarters
Cambridge, MA
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
2130606
Former names
Gazelle Parent, Inc. (until Aug 3, 2026)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.